<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36729627</PMID><DateCompleted><Year>2023</Year><Month>04</Month><Day>14</Day></DateCompleted><DateRevised><Year>2023</Year><Month>08</Month><Day>17</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1558-2035</ISSN><JournalIssue CitedMedium="Internet"><Volume>24</Volume><Issue>Suppl 1</Issue><PubDate><Year>2023</Year><Month>Apr</Month><Day>01</Day></PubDate></JournalIssue><Title>Journal of cardiovascular medicine (Hagerstown, Md.)</Title><ISOAbbreviation>J Cardiovasc Med (Hagerstown)</ISOAbbreviation></Journal><ArticleTitle>Impact of COVID-19 on the cardiovascular health of women: a review by the Italian Society of Cardiology Working Group on 'gender cardiovascular diseases'.</ArticleTitle><Pagination><StartPage>e15</StartPage><EndPage>e23</EndPage><MedlinePgn>e15-e23</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.2459/JCM.0000000000001398</ELocationID><Abstract><AbstractText>The coronavirus disease 19 (COVID-19), due to coronavirus 2 (SARS-CoV-2) infection, presents with an extremely heterogeneous spectrum of symptoms and signs. COVID-19 susceptibility and mortality show a significant sex imbalance, with men being more prone to infection and showing a higher rate of hospitalization and mortality than women. In particular, cardiovascular diseases (preexistent or arising upon infection) play a central role in COVID-19 outcomes, differently in men and women. This review will discuss the potential mechanisms accounting for sex/gender influence in vulnerability to COVID-19. Such variability can be ascribed to both sex-related biological factors and sex-related behavioural traits. Sex differences in cardiovascular disease and COVID-19 involve the endothelial dysfunction, the innate immune system and the renin-angiotensin system (RAS). Furthermore, the angiotensin-converting enzyme 2 (ACE2) is involved in disease pathogenesis in cardiovascular disease and COVID-19 and it shows hormone-dependent actions. The incidence of myocardial injury during COVID-19 is sex-dependent, predominantly in association with a greater degree of inflammation and coagulation disorders among men. Its pathogenesis is not fully elucidated, but the main theories foresee a direct role for the ACE2 receptor, the hyperimmune response and the RAS imbalance, which may also lead to isolated presentation of COVID-19-mediated myopericarditis. Moreover, the latest evidence on cardiovascular diseases and their relationship with COVID-19 during pregnancy will be discussed. Finally, authors will analyse the prevalence of the long-covid syndrome between the two sexes and its impact on the quality of life and cardiovascular health.</AbstractText><CopyrightInformation>Copyright &#xa9; 2022 Italian Federation of Cardiology - I.F.C. All rights reserved.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Moscucci</LastName><ForeName>Federica</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Clinical and Internal Medicine, Anesthesiology and Cardiovascular Sciences, University of Rome 'Sapienza', Policlinico Umberto I, Rome.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gallina</LastName><ForeName>Sabina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Neuroscience, Imaging and Clinical Sciences, University of Chieti-Pescara, Chieti.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bucciarelli</LastName><ForeName>Valentina</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Paediatric and Congenital Cardiac Surgery and Cardiology, Azienda Ospedaliero-Universitaria Ospedali Riuniti Ancona 'Umberto I, G. M. Lancisi, G. Salesi', Ancona.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aimo</LastName><ForeName>Alberto</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Cardiology Division, Fondazione Toscana Gabriele Monasterio.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Scuola Superiore Sant'Anna, Pisa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pel&#xe0;</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medicine and Surgery, University of Parma.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of General and Specialistic Medicine, University-Hospital of Parma, Parma.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cadeddu-Dessalvi</LastName><ForeName>Christian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nodari</LastName><ForeName>Savina</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Medical and Surgical Specialties, Radiological Sciences and Public Health, University of Brescia, Brescia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maffei</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Cardiovascular and Gynaecological Endocrinology Unit, Fondazione G Monasterio CNR-Regione Toscana.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Meloni</LastName><ForeName>Antonella</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Radiology, Fondazione G Monasterio CNR-Regione Toscana, Pisa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Deidda</LastName><ForeName>Martino</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mercuro</LastName><ForeName>Giuseppe</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Department of Medical Sciences and Public Health, University of Cagliari, Cagliari.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Pedrinelli</LastName><ForeName>Roberto</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Surgical, Medical and Molecular Pathology and Critical Care Medicine, University of Pisa, Pisa.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Penco</LastName><ForeName>Maria</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Life, Health and Environmental Sciences, University of L'Aquila, L'Aquila.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sciomer</LastName><ForeName>Susanna</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Clinical and Internal Medicine, Anesthesiology and Cardiovascular Sciences, University of Rome 'Sapienza', Policlinico Umberto I, Rome.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mattioli</LastName><ForeName>Anna Vittoria</ForeName><Initials>AV</Initials><AffiliationInfo><Affiliation>Surgical, Medical and Dental Department of Morphological Sciences Related to Transplant, Oncology and Regenerative Medicine, University of Modena and Reggio Emilia, Modena, Italy.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016454">Review</PublicationType><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2022</Year><Month>12</Month><Day>15</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>J Cardiovasc Med (Hagerstown)</MedlineTA><NlmUniqueID>101259752</NlmUniqueID><ISSNLinking>1558-2027</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>EC 3.4.17.23</RegistryNumber><NameOfSubstance UI="D000085962">Angiotensin-Converting Enzyme 2</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.15.1</RegistryNumber><NameOfSubstance UI="D007703">Peptidyl-Dipeptidase A</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="Y">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName><QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000085962" MajorTopicYN="N">Angiotensin-Converting Enzyme 2</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000094024" MajorTopicYN="N">Post-Acute COVID-19 Syndrome</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011788" MajorTopicYN="N">Quality of Life</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007703" MajorTopicYN="N">Peptidyl-Dipeptidase A</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012084" MajorTopicYN="N">Renin-Angiotensin System</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002309" MajorTopicYN="Y">Cardiology</DescriptorName></MeshHeading></MeshHeadingList><CoiStatement>There are no conflicts of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>4</Month><Day>14</Day><Hour>6</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>3</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>2</Day><Hour>11</Hour><Minute>56</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2022</Year><Month>12</Month><Day>15</Day></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36729627</ArticleId><ArticleId IdType="pmc">PMC10100638</ArticleId><ArticleId IdType="doi">10.2459/JCM.0000000000001398</ArticleId><ArticleId IdType="pii">01244665-202304001-00003</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhang H, Wu Y, He Y, et al. . Age-related risk factors and complications of patients with COVID-19: a population-based retrospective study. Front Med (Lausanne) 2022; 8:757459.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8786909</ArticleId><ArticleId IdType="pubmed">35087843</ArticleId></ArticleIdList></Reference><Reference><Citation>Clark A, Jit M, Warren-Gash C, et al. . Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study. Centre for the Mathematical Modelling of Infectious Diseases COVID-19 working group. Lancet Glob Health 2020; 8:e1003&#x2013;e1017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7295519</ArticleId><ArticleId IdType="pubmed">32553130</ArticleId></ArticleIdList></Reference><Reference><Citation>Rezel-Potts E, Douiri A, Sun X, Chowienczyk PJ, Shah AM, Gulliford MC. Cardiometabolic outcomes up to 12&#x200a;months after COVID-19 infection: a matched cohort study in the UK. PLoS Med 2022; 19:e1004052.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9295991</ArticleId><ArticleId IdType="pubmed">35853019</ArticleId></ArticleIdList></Reference><Reference><Citation>Arcari L, Luciani M, Cacciotti L, et al. . Coronavirus disease 2019 in patients with cardiovascular disease: clinical features and implications on cardiac biomarkers assessment. J Cardiovasc Med (Hagerstown) 2021; 22:832&#x2013;839.</Citation><ArticleIdList><ArticleId IdType="pubmed">34482324</ArticleId></ArticleIdList></Reference><Reference><Citation>Guo H, Shen Y, Wu N, Sun X. J Myocardial injury in severe and critical coronavirus disease 2019 patients. Card Surg 2021; 36:82&#x2013;88.</Citation><ArticleIdList><ArticleId IdType="pubmed">33135188</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu H, Hou K, Xu R, et al. . Clinical characteristics and risk factors of cardiac involvement in COVID-19. J Am Heart Assoc 2020; 9:e016807.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7726994</ArticleId><ArticleId IdType="pubmed">32806998</ArticleId></ArticleIdList></Reference><Reference><Citation>El Aidaoui K, Benhamou RA, Haoudar A, et al. . Sex differences in COVID-19 outcomes. Cureus 2022; 14:e25760.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9268490</ArticleId><ArticleId IdType="pubmed">35812606</ArticleId></ArticleIdList></Reference><Reference><Citation>Tejpal A, Gianos E, Cerise J, et al. . Sex-based differences in COVID-19 outcomes. J Womens Health (Larchmt) 2021; 30:492&#x2013;501.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8182657</ArticleId><ArticleId IdType="pubmed">33885345</ArticleId></ArticleIdList></Reference><Reference><Citation>Lombardi CM, Specchia C, Conforti F, et al. . Sex-related differences in patients with coronavirus disease 2019: results of the Cardio-COVID-Italy multicentre study. J Cardiovasc Med (Hagerstown) 2022; 23:254&#x2013;263.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10484185</ArticleId><ArticleId IdType="pubmed">35287158</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushita Y, Yokoyama T, Hayakawa K, et al. . We should pay more attention to sex differences to predict the risk of severe COVID-19: men have the same risk of worse. J Epidemiol 2022; doi: 10.2188/jea.JE20220056. [Online ahead of print].</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9727213</ArticleId><ArticleId IdType="pubmed">35851563</ArticleId></ArticleIdList></Reference><Reference><Citation>Percivale I, Danna PSC, Falaschi Z, et al. . Men and women affected by Sars-CoV-2 pneumonia: same CT features but different outcome. Clin Radiol 2021; 76:235e25&#x2013;235e34.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7732229</ArticleId><ArticleId IdType="pubmed">33358500</ArticleId></ArticleIdList></Reference><Reference><Citation>Townsend N, Kazakiewicz D, Lucy Wright F, et al. . Epidemiology of cardiovascular disease in Europe. Nat Rev Cardiol 2022; 19:133&#x2013;143.</Citation><ArticleIdList><ArticleId IdType="pubmed">34497402</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou F, Yu T, Du R, et al. . Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet 2020; 395:1054&#x2013;1062. doi: 10.1016/S0140-6736(20)30566-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270627</ArticleId><ArticleId IdType="pubmed">32171076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciarelli V, Nasi M, Bianco F, et al. . Depression pandemic and cardiovascular risk in the COVID-19 era and long COVID syndrome: gender makes a difference. Trends Cardiovasc Med 2022; 32:12&#x2013;17.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8490128</ArticleId><ArticleId IdType="pubmed">34619336</ArticleId></ArticleIdList></Reference><Reference><Citation>Bucciarelli V, Caterino AL, Bianco F, et al. . Depression and cardiovascular disease: the deep blue sea of women's heart. Trends Cardiovasc Med 2020; 30:170&#x2013;176.</Citation><ArticleIdList><ArticleId IdType="pubmed">31109802</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia M, Mulvagh SL, Merz CN, Buring JE, Manson JE. Cardiovascular disease in women: clinical perspectives. Circ Res 2016; 118:1273&#x2013;1293.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4834856</ArticleId><ArticleId IdType="pubmed">27081110</ArticleId></ArticleIdList></Reference><Reference><Citation>Agarwala A, Michos ED, Samad Z, Ballantyne CM, Virani SS. The use of sex-specific factors in the assessment of women's cardiovascular risk. Circulation 2020; 141:592&#x2013;599.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7032610</ArticleId><ArticleId IdType="pubmed">32065772</ArticleId></ArticleIdList></Reference><Reference><Citation>Kong KA, Jung S, Yu M, Park J, Kang IS. Association between cardiovascular risk factors and the severity of coronavirus disease 2019: nationwide epidemiological study in Korea. Front Cardiovasc Med 2021; 8:732518.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8458703</ArticleId><ArticleId IdType="pubmed">34568465</ArticleId></ArticleIdList></Reference><Reference><Citation>Sharma AK, Baig VN, Sharma S, et al. . Cardiovascular risk factors and outcomes in COVID-19: a hospital-based study in India. PLoS Glob Public Health 2022; 2:e0000234.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10021757</ArticleId><ArticleId IdType="pubmed">36962181</ArticleId></ArticleIdList></Reference><Reference><Citation>Collard D, Nurmohamed NS, Kaiser Y, et al. . Cardiovascular risk factors and COVID-19 outcomes in hospitalised patients: a prospective cohort study. BMJ Open 2021; 11:e045482.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7902321</ArticleId><ArticleId IdType="pubmed">33619201</ArticleId></ArticleIdList></Reference><Reference><Citation>Matsushita K, Ding N, Kou M, et al. . The relationship of COVID-19 severity with cardiovascular disease and its traditional risk factors: a systematic review and meta-analysis. Global Heart 2020; 15:64.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7546112</ArticleId><ArticleId IdType="pubmed">33150129</ArticleId></ArticleIdList></Reference><Reference><Citation>Bae S, Kim SR, Kim M, et al. . Impact of cardiovascular disease and risk factors on fatal outcomes in patients with COVID-19 according to age: a systematic review and meta-analysis. Heart 2021; 107:373&#x2013;380.</Citation><ArticleIdList><ArticleId IdType="pubmed">33334865</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciomer S, De Carlo C, Moscucci F, Maffei S. Age at menopause: a fundamental data of interest to acquire in female patients&#x2019; anamnesis. Int J Cardiol 2016; 215:358&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pubmed">27128561</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattioli AV, Sciomer S, Moscucci F, et al. . Cardiovascular prevention in women: a narrative review from the Italian Society of Cardiology working groups on &#x2018;Cardiovascular Prevention, Hypertension and peripheral circulation&#x2019; and on &#x2018;Women Disease&#x2019;. J Cardiovasc Med (Hagerstown) 2019; 20:575&#x2013;583.</Citation><ArticleIdList><ArticleId IdType="pubmed">31246698</ArticleId></ArticleIdList></Reference><Reference><Citation>Tsai S, Nguyen H, Ebrahimi R, et al. . COVID-19 associated mortality and cardiovascular disease outcomes among US women veterans. Sci Rep 2021; 11:8497.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8055870</ArticleId><ArticleId IdType="pubmed">33875764</ArticleId></ArticleIdList></Reference><Reference><Citation>Haitao T, Vermunt JV, Abeykoon J, et al. . COVID-19 and sex differences: mechanisms and biomarkers. Mayo Clin Proc 2020; 95:2189&#x2013;2203.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7402208</ArticleId><ArticleId IdType="pubmed">33012349</ArticleId></ArticleIdList></Reference><Reference><Citation>Gheblawi M, Wang K, Viveiros A, et al. . Angiotensin-converting enzyme 2: SARS-CoV-2 receptor and regulator of the renin-angiotensin system: celebrating the 20th anniversary of the discovery of ACE2. Circulation research 2020; 126:1456&#x2013;1474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7188049</ArticleId><ArticleId IdType="pubmed">32264791</ArticleId></ArticleIdList></Reference><Reference><Citation>Aimo A, Vergaro G, Passino C, Clerico A. Evaluation of pathophysiological relationships between renin-angiotensin and ACE-ACE2 systems in cardiovascular disorders: from theory to routine clinical practice in patients with heart failure. Crit Rev Clin Lab Sci 2021; 58:530&#x2013;545.</Citation><ArticleIdList><ArticleId IdType="pubmed">34196254</ArticleId></ArticleIdList></Reference><Reference><Citation>Coutard B, Valle C, de Lamballerie X, Canard B, Seidah NG, Decroly E. The spike glycoprotein of the new coronavirus 2019-nCoV contains a furin-like cleavage site absent in CoV of the same clade. Antiviral Res 2020; 176:104742.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7114094</ArticleId><ArticleId IdType="pubmed">32057769</ArticleId></ArticleIdList></Reference><Reference><Citation>Walls AC, Park YJ, Tortorici MA, Wall A, McGuire AT, Veesler D. Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein. Cell 2020; 181:281&#x2013;292.e6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7102599</ArticleId><ArticleId IdType="pubmed">32155444</ArticleId></ArticleIdList></Reference><Reference><Citation>Tukiainen T, Villani AC, Yen A, et al. . Landscape of X chromosome inactivation across human tissues. Nature 2017; 550:244&#x2013;248.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5685192</ArticleId><ArticleId IdType="pubmed">29022598</ArticleId></ArticleIdList></Reference><Reference><Citation>Bukowska A, Spiller L, Wolke C, et al. . Protective regulation of the ACE2/ACE gene expression by estrogen in human atrial tissue from elderly men. Exp Biol Med (Maywood) 2017; 242:1412&#x2013;1423.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5544171</ArticleId><ArticleId IdType="pubmed">28661206</ArticleId></ArticleIdList></Reference><Reference><Citation>Li MY, Li L, Zhang Y, Wang XS. Expression of the SARS-CoV-2 cell receptor gene ACE2 in a wide variety of human tissues. Infect Dis Poverty 2020; 9:45.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7186534</ArticleId><ArticleId IdType="pubmed">32345362</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung JM, Yang CX, Tam A, et al. . ACE-2 expression in the small airway epithelia of smokers and COPD patients: implications for COVID-19. Eur Respir J 2020; 55:2000688.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7144263</ArticleId><ArticleId IdType="pubmed">32269089</ArticleId></ArticleIdList></Reference><Reference><Citation>Chakladar J, Shende N, Li WT, Rajasekaran M, Chang EY, Ongkeko WM. Smoking-mediated upregulation of the androgen pathway leads to increased SARS-CoV-2 susceptibility. Int J Mol Sci 2020; 21:3627.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7279323</ArticleId><ArticleId IdType="pubmed">32455539</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas JM, Heinlein C, Kim T, et al. . The androgen-regulated protease TMPRSS2 activates a proteolytic cascade involving components of the tumor microenvironment and promotes prostate cancer metastasis. Cancer discovery 2014; 4:1310&#x2013;1325.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4409786</ArticleId><ArticleId IdType="pubmed">25122198</ArticleId></ArticleIdList></Reference><Reference><Citation>Montopoli M, Zumerle S, Vettor R, et al. . Androgen-deprivation therapies for prostate cancer and risk of infection by SARS-CoV-2: a population-based study (N&#x200a;=&#x200a;4532). Ann Oncol 2020; 31:1040&#x2013;1045.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7202813</ArticleId><ArticleId IdType="pubmed">32387456</ArticleId></ArticleIdList></Reference><Reference><Citation>Petrilli CM, Jones SA, Yang J, et al. . Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study. BMJ 2020; 369:m1966.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7243801</ArticleId><ArticleId IdType="pubmed">32444366</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F, Huang Y, Guo Y, et al. . Association of inflammatory markers with the severity of COVID-19: a meta-analysis. Int J Infect Dis 2020; 96:467&#x2013;474.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7233226</ArticleId><ArticleId IdType="pubmed">32425643</ArticleId></ArticleIdList></Reference><Reference><Citation>Kermali M, Khalsa RK, Pillai K, Ismail Z, Harky A. The role of biomarkers in diagnosis of COVID-19: a systematic review. Life Sci 2020; 254:117788.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7219356</ArticleId><ArticleId IdType="pubmed">32475810</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin L, Li X, Shi J, et al. . Gendered effects on inflammation reaction and outcome of COVID-19 patients in Wuhan. J Med Virol 2020; 92:2684&#x2013;2692.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7300463</ArticleId><ArticleId IdType="pubmed">32497297</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng F, Li L, Zeng J, et al. . Can we predict the severity of coronavirus disease 2019 with a routine blood test? Pol Arch Intern Med 2020; 130:400&#x2013;406.</Citation><ArticleIdList><ArticleId IdType="pubmed">32356642</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu J, Liu Y, Xiang P, et al. . Neutrophil-to-lymphocyte ratio predicts critical illness patients with 2019 coronavirus disease in the early stage. J Transl Med 2020; 18:206.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7237880</ArticleId><ArticleId IdType="pubmed">32434518</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan X, Li F, Wang X, et al. . Neutrophil to lymphocyte ratio as prognostic and predictive factor in patients with coronavirus disease 2019: a retrospective cross-sectional study. J Med Virol 2020; 92:2573&#x2013;2581.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7283791</ArticleId><ArticleId IdType="pubmed">32458459</ArticleId></ArticleIdList></Reference><Reference><Citation>M&#xfc;ller U, Steinhoff U, Reis LF, et al. . Functional role of type I and type II interferons in antiviral defense. Science 1994; 264:1918&#x2013;1921.</Citation><ArticleIdList><ArticleId IdType="pubmed">8009221</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson DP, Lorenzo ME, Jian W, Klein SL. Elevated 17&#x3b2;-estradiol protects females from influenza A virus pathogenesis by suppressing inflammatory responses. PLoS Pathogens 2011; 7:e1002149.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3145801</ArticleId><ArticleId IdType="pubmed">21829352</ArticleId></ArticleIdList></Reference><Reference><Citation>Scotland RS, Stables MJ, Madalli S, Watson P, Gilroy DW. Sex differences in resident immune cell phenotype underlie more efficient acute inflammatory responses in female mice. Blood 2011; 118:5918&#x2013;5927.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5363818</ArticleId><ArticleId IdType="pubmed">21911834</ArticleId></ArticleIdList></Reference><Reference><Citation>Webb K, Peckham H, Radziszewska A, et al. . Sex and pubertal differences in the Type 1 interferon pathway associate with both X chromosome number and serum sex hormone concentration. Front Immunol 2018; 9:3167.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6345344</ArticleId><ArticleId IdType="pubmed">30705679</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Wang Y, Li X, et al. . Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China. Lancet 2020; 395:497&#x2013;506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7159299</ArticleId><ArticleId IdType="pubmed">31986264</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei JF, Huang FY, Xiong TY, et al. . Acute myocardial injury is common in patients with COVID-19 and impairs their prognosis. Heart 2020; 106:1154&#x2013;1159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7398466</ArticleId><ArticleId IdType="pubmed">32354798</ArticleId></ArticleIdList></Reference><Reference><Citation>Madjid M, Vela D, Khalili-Tabrizi H, Casscells SW, Litovsky S. Systemic infections cause exaggerated local inflammation in atherosclerotic coronary arteries: clues to the triggering effect of acute infections on acute coronary syndromes. Tex Heart Inst J 2007; 34:11&#x2013;18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC1847934</ArticleId><ArticleId IdType="pubmed">17420787</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang N, Li D, Wang X, Sun Z. Abnormal coagulation parameters are associated with poor prognosis in patients with novel coronavirus pneumonia. J Thromb Haemost 2020; 18:844&#x2013;847.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7166509</ArticleId><ArticleId IdType="pubmed">32073213</ArticleId></ArticleIdList></Reference><Reference><Citation>Klein SL, Flanagan KL. Sex differences in immune responses. Nat Rev Immunol 2016; 16:626&#x2013;638.</Citation><ArticleIdList><ArticleId IdType="pubmed">27546235</ArticleId></ArticleIdList></Reference><Reference><Citation>Wray S, Arrowsmith S. The physiological mechanisms of the sexbased difference in outcomes of COVID19 infection. Front Physiol 2021; 12:627260.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7900431</ArticleId><ArticleId IdType="pubmed">33633588</ArticleId></ArticleIdList></Reference><Reference><Citation>Mauvais-Jarvis F, Klein SL, Levin ER. Estradiol, progesterone, immunomodulation, and COVID-19 outcomes. Endocrinology 2020; 161:bqaa127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7438701</ArticleId><ArticleId IdType="pubmed">32730568</ArticleId></ArticleIdList></Reference><Reference><Citation>Archer SL, Huang JM, Hampl V, et al. . Nitric oxide and cGMP cause vasorelaxation by activation of a charybdotoxin-sensitive K channel by cGMP-dependent protein kinase. Proc Natl Acad Sci U S A 1994; 91:7583&#x2013;7587.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC44446</ArticleId><ArticleId IdType="pubmed">7519783</ArticleId></ArticleIdList></Reference><Reference><Citation>MacRitchie AN, Jun SS, Chen Z, et al. . Estrogen upregulates endothelial nitric oxide synthase gene expression in fetal pulmonary artery endothelium. Circ Res 1997; 81:355&#x2013;362.</Citation><ArticleIdList><ArticleId IdType="pubmed">9285637</ArticleId></ArticleIdList></Reference><Reference><Citation>Salerni S, Di Francescomarino S, Cadeddu C, Acquistapace F, Maffei S, Gallina S. The different role of sex hormones on female cardiovascular physiology and function: not only oestrogens. Eur J Clin Invest 2015; 45:634&#x2013;645.</Citation><ArticleIdList><ArticleId IdType="pubmed">25845675</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu PP, Blet A, Smyth D, Li H. The Science underlying COVID-19: implications for the cardiovascular system. Circulation 2020; 142:68&#x2013;78.</Citation><ArticleIdList><ArticleId IdType="pubmed">32293910</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan P, Wang X, Liu D. The potential mechanism of mitochondrial dysfunction in septic cardiomyopathy. J Int Med Res 2018; 46:2157&#x2013;2169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6023059</ArticleId><ArticleId IdType="pubmed">29637807</ArticleId></ArticleIdList></Reference><Reference><Citation>Kanczkowski W, Evert K, Stadtm&#xfc;ller M, et al. . COVID-19 targets human adrenal glands. lancet diabetes endocrinol 2021. Lancet Diabetes Endocrinol 2022; 10:13&#x2013;16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8601687</ArticleId><ArticleId IdType="pubmed">34801110</ArticleId></ArticleIdList></Reference><Reference><Citation>Thygesen K, Alpert JS, Jaffe AS, et al. . ESC Scientific Document Group. Fourth universal definition of myocardial infarction. Eur Heart J 2019; 40:237&#x2013;269.</Citation><ArticleIdList><ArticleId IdType="pubmed">30165617</ArticleId></ArticleIdList></Reference><Reference><Citation>Giustino G, Pinney SP, Lala A, et al. . Coronavirus and cardiovascular disease, myocardial injury, and arrhythmia: JACC Focus Seminar. J Am Coll Cardiol 2020; 76:2011&#x2013;2023.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7572122</ArticleId><ArticleId IdType="pubmed">33092737</ArticleId></ArticleIdList></Reference><Reference><Citation>Diaz-Arocutipa C, Saucedo-Chinchay J, Imazio M. Pericarditis in patients with COVID-19: a systematic review. J Cardiovasc Med 2021; 22:693&#x2013;700.</Citation><ArticleIdList><ArticleId IdType="pubmed">33927144</ArticleId></ArticleIdList></Reference><Reference><Citation>Caforio AL, Pankuweit S, Arbustini E, et al. . European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J 2013; 34:2636&#x2013;2648. 2648a&#x2013;2648d.</Citation><ArticleIdList><ArticleId IdType="pubmed">23824828</ArticleId></ArticleIdList></Reference><Reference><Citation>Escher F, Pietsch H, Aleshcheva G, et al. . Detection of viral SARS-CoV-2 genomes and histopathological changes in endomyocardial biopsies. ESC Heart Fail 2020; 7:2440&#x2013;2524.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7307078</ArticleId><ArticleId IdType="pubmed">32529795</ArticleId></ArticleIdList></Reference><Reference><Citation>Lindner D, Fitzek A, Brauninger H, et al. . Association of cardiac infection with SARS-CoV-2 in confirmed COVID-19 autopsy cases. JAMA Cardiol 2020; 5:1281&#x2013;1285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7385672</ArticleId><ArticleId IdType="pubmed">32730555</ArticleId></ArticleIdList></Reference><Reference><Citation>Shay DK, Shimabukuro TT, DeStefano F. Myocarditis occurring after immunization with mRNA-based COVID-19 vaccines. JAMA Cardiol 2021; 6:1115&#x2013;1117.</Citation><ArticleIdList><ArticleId IdType="pubmed">34185047</ArticleId></ArticleIdList></Reference><Reference><Citation>Petersen BW, Damon IK, Pertowski CA, et al. . Clinical guidance for smallpox vaccine use in a postevent vaccination program. MMWR Recomm Rep 2015; 64:1&#x2013;26.</Citation><ArticleIdList><ArticleId IdType="pubmed">25695372</ArticleId></ArticleIdList></Reference><Reference><Citation>Lassi ZS, Ana A, Das JK, et al. . A systematic review and meta-analysis of data on pregnant women with confirmed COVID-19: clinical presentation, and pregnancy and perinatal outcomes based on COVID-19 severity. J Glob Health 2021; 11:05018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8248750</ArticleId><ArticleId IdType="pubmed">34221361</ArticleId></ArticleIdList></Reference><Reference><Citation>Allotey J, Fernandez S, Bonet M, et al. . Clinical manifestations, risk factors, and maternal and perinatal outcomes of coronavirus disease 2019 in pregnancy: living systematic review and meta-analysis. BMJ 2020; 370:m3320.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7459193</ArticleId><ArticleId IdType="pubmed">32873575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wei SQ, Bilodeau-Bertrand M, Liu S, Auger N. The impact of COVID-19 on pregnancy outcomes: a systematic review and meta-analysis. CMAJ 2021; 193:E540&#x2013;e548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8084555</ArticleId><ArticleId IdType="pubmed">33741725</ArticleId></ArticleIdList></Reference><Reference><Citation>Villar J, Ariff S, Gunier RB, et al. . Maternal and neonatal morbidity and mortality among pregnant women with and without COVID-19 infection: the INTERCOVID Multinational Cohort Study. JAMA Pediatrics 2021; 175:817&#x2013;826.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8063132</ArticleId><ArticleId IdType="pubmed">33885740</ArticleId></ArticleIdList></Reference><Reference><Citation>Metz TD, Clifton RG, Hughes BL, et al. . Association of SARS-CoV-2 infection with serious maternal morbidity and mortality from obstetric complications. JAMA 2022; 327:748&#x2013;759.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8822445</ArticleId><ArticleId IdType="pubmed">35129581</ArticleId></ArticleIdList></Reference><Reference><Citation>Muyayalo KP, Huang DH, Zhao SJ, Xie T, Mor G, Liao AH. COVID-19 and Treg/Th17 imbalance: potential relationship to pregnancy outcomes. Am J Reprod Immunol 2020; 84:e13304.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7404618</ArticleId><ArticleId IdType="pubmed">32662111</ArticleId></ArticleIdList></Reference><Reference><Citation>Mercedes BR, Serwat A, Naffaa L, et al. . New-onset myocardial injury in pregnant patients with coronavirus disease 2019: a case series of 15 patients. Am J Obstet Gynecol 2021; 224:387.e381&#x2013;387.e389.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7577917</ArticleId><ArticleId IdType="pubmed">33098814</ArticleId></ArticleIdList></Reference><Reference><Citation>Blakeway H, Prasad S, Kalafat E, et al. . COVID-19 vaccination during pregnancy: coverage and safety. Am J Obstet Gynecol 2022; 226:236.e231&#x2013;236.e214.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8352848</ArticleId><ArticleId IdType="pubmed">34389291</ArticleId></ArticleIdList></Reference><Reference><Citation>Kotlyar M, Grechukhina O, Chen A, et al. . Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol 2021; 224:35&#x2013;53.e33.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7392880</ArticleId><ArticleId IdType="pubmed">32739398</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Chen H, An M, et al. . Recommendations for breastfeeding during Coronavirus Disease 2019 (COVID-19) pandemic. Int Breastfeed J 2022; 17:28.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8995694</ArticleId><ArticleId IdType="pubmed">35410357</ArticleId></ArticleIdList></Reference><Reference><Citation>Penna C, Mercurio V, Tocchetti CG, Pagliaro P. Sex-related differences in COVID-19 lethality. Br J Pharmacol 2020; 177:4375&#x2013;4385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7405496</ArticleId><ArticleId IdType="pubmed">32698249</ArticleId></ArticleIdList></Reference><Reference><Citation>Gebhard C, Regitz-Zagrosek V, Neuhauser HK, Morgan R, Klein SL. Impact of sex and gender on COVID-19 outcomes in Europe. Biol Sex Differ 2020; 11:29.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7247289</ArticleId><ArticleId IdType="pubmed">32450906</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Stadio A, Ricci G, Greco A, de Vincentiis M, Ralli M. Mortality rate and gender differences in COVID-19 patients dying in Italy: a comparison with other countries. Eur Rev Med Pharmacol Sci 2020; 24:4066&#x2013;4067.</Citation><ArticleIdList><ArticleId IdType="pubmed">32374012</ArticleId></ArticleIdList></Reference><Reference><Citation>Sykes DL, Holdsworth L, Jawad N, Gunasekera P, Morice AH, Crook MG. Post-COVID-19 symptom burden: what is Long-COVID and how should we manage it? Lung 2021; 199:113&#x2013;119.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7875681</ArticleId><ArticleId IdType="pubmed">33569660</ArticleId></ArticleIdList></Reference><Reference><Citation>Pela&#x2019; G, Goldoni M, Cavalli C, et al. . Long-term cardiac sequelae in patients referred into a diagnostic post-COVID-19 pathway: the different impacts on the right and left ventricles. Diagnostics 2021; 11:2059.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8623572</ArticleId><ArticleId IdType="pubmed">34829406</ArticleId></ArticleIdList></Reference><Reference><Citation>Sigfrid L, Drake TM, Pauley E, et al. . Long Covid in adults discharged from UK hospitals after Covid-19: a prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol. Lancet Reg Heal Eur 2021; 8:100186.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8343377</ArticleId><ArticleId IdType="pubmed">34386785</ArticleId></ArticleIdList></Reference><Reference><Citation>Bai F, Tomasoni D, Falcinella C, et al. . Female gender is associated with long COVID syndrome: a prospective cohort study. Clin Microbiol Infect 2022; 28:611e9&#x2013;611e16.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8575536</ArticleId><ArticleId IdType="pubmed">34763058</ArticleId></ArticleIdList></Reference><Reference><Citation>Pela&#x2019; G, Goldoni M, Solinas E, et al. . Sex-related differences in long-COVID-19 syndrome. J Womens Health 2022; 31:620&#x2013;630.</Citation><ArticleIdList><ArticleId IdType="pubmed">35333613</ArticleId></ArticleIdList></Reference><Reference><Citation>Fern&#xe1;ndez-De-las-Pe&#xf1;as C, Mart&#xed;n-Guerrero JD, Pellicer-Valero &#xd3;J, et al. . Female sex is a risk factor associated with long-term post-COVID related-symptoms but not with COVID-19 symptoms: the LONG-COVID-EXP-CM multicenter study. J Clin Med 2022; 11:413.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8778106</ArticleId><ArticleId IdType="pubmed">35054108</ArticleId></ArticleIdList></Reference><Reference><Citation>Indolfi C, Barill&#xe0; F, Ciccone MM, et al. . Expert consensus document of the Italian Society of Cardiology (SIC): post acute Cardiovascular sequelae of SARS-CoV-2 infection. G Ital Cardiol 2022; 23:491&#x2013;503.</Citation><ArticleIdList><ArticleId IdType="pubmed">35771014</ArticleId></ArticleIdList></Reference><Reference><Citation>Novelli G, Michela Biancolella M, Novelli G, Michela Biancolella M. COVID-19 and molecular genetics. Genes 2022; 13:676.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9025328</ArticleId><ArticleId IdType="pubmed">35456482</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganesh R, Grach SL, Ghosh AK, et al. . The female-predominant persistent immune dysregulation of the post-COVID syndrome. Mayo Clin Proc 2022; 97:454&#x2013;464.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8817110</ArticleId><ArticleId IdType="pubmed">35135695</ArticleId></ArticleIdList></Reference><Reference><Citation>Vogel B, Acevedo M, Appelman Y, et al. . The Lancet women and cardiovascular disease Commission: reducing the global burden by 2030. Lancet 2021; 397:2385&#x2013;2438.</Citation><ArticleIdList><ArticleId IdType="pubmed">34010613</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciomer S, Moscucci F, Maffei S, Gallina S, Mattioli AV. Prevention of cardiovascular risk factors in women: the lifestyle paradox and stereotypes we need to defeat. Eur J Prev Cardiol 2019; 26:609&#x2013;610.</Citation><ArticleIdList><ArticleId IdType="pubmed">30373379</ArticleId></ArticleIdList></Reference><Reference><Citation>Sciomer S, Gallina S, Mattioli AV, Agostoni PG, Moscucci F. Slow and steady wins the race: better walking than running: the turtle's lesson in the times of COVID-19. Heart Lung 2021; 50:587&#x2013;588.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8169339</ArticleId><ArticleId IdType="pubmed">34090175</ArticleId></ArticleIdList></Reference><Reference><Citation>Mattioli AV, Sciomer S, Maffei S, Gallina S. Lifestyle and stress management in women during COVID-19 pandemic: impact on cardiovascular risk burden. Am J Lifestyle Med 2020; 15:356&#x2013;359.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8120604</ArticleId><ArticleId IdType="pubmed">34025328</ArticleId></ArticleIdList></Reference><Reference><Citation>Ricci F, Izzicupo P, Moscucci F, et al. . Recommendations for physical inactivity and sedentary behavior during the Coronavirus Disease (COVID-19) pandemic. Front Public Health 2020; 8:199.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7235318</ArticleId><ArticleId IdType="pubmed">32574294</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>